← SynDRA
OTESECONAZOLE
SynDRA canonical compound SYN0038082 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx |
|---|
| Mechanism of action | other antifungal |
|---|
| Indication | vulvovaginal candidiasis |
|---|
| Disease area | infectious disease |
|---|
All known targets
- CYP2C19
- CYP2C9
- CYP3A4
- CYP51A1
- Candi ERG11
- ERG11
Mechanisms of action (all sources)
- Candi ERG11 INHIBITOR
- CYP51A1 INHIBITOR
- ERG11 INHIBITOR
Drug classes
- Azole Antifungal
- Breast Cancer Resistance Protein Inhibitors
- Antifungal Agents
- other antifungal
ATC classes
- J02A · ANTIMYCOTICS FOR SYSTEMIC USE
Cross-references
Synonyms
- VIVJOA
- Vivjoa
- vivijoa
- VT-1161
- Oteseconazol
- VT-1129
- Metalloenzyme inhibitors (fungal infection)
- VT-1235
- Metalloenzyme inhibitors (fungal infection), Viamet
- Otesaconazole
- UNII-VHH774W97N
- VHH774W97N
- CHEMBL3311228
- Oteseconazole [USAN]
- Oteseconazole (USAN/INN)
- SCHEMBL17113021
- BDBM50046187
- WHO 10138
- DB13055
- SB17420
- HY-17643
- CS-0016914
- D11785
- Q27291837
- OTESECONAZOLE, (+)-
- oteseconazol
- oteseconazolum
- RefChem:57369
- C23H16F7N5O2
- Vivijoa (TN)
- Oteseconazole (Standard)
- OTESECONAZOLE [INN]
- OTESECONAZOLE [WHO-DD]
- orb1307922
- SCHEMBL29376789
- SCHEMBL29689915
- CHEBI:188153
- IDUYJRXRDSPPRC-NRFANRHFSA-N
Look up OTESECONAZOLE in the interactive SynDRA portal →